Please try another search
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.
Name | Age | Since | Title |
---|---|---|---|
Ilan Danieli | 49 | 2017 | Founder, President, CEO & Director |
Richard Alvin Sandberg | 79 | 2019 | Independent Chairman of the Board |
Gil Mor | - | - | Member of Scientific Advisory Board |
David Seth Cohen | 63 | 2017 | Independent Director |
Mike Makrigiorgos | - | - | Member of Scientific Advisory Board |
Ronald A. Andrews | 62 | 2021 | Independent Director |
Mark Rimer | 43 | 2012 | Board Observer |
Douglas Carl Fisher | 48 | 2017 | Board Observer |
Kathleen D. LaPorte | 62 | 2018 | Independent Non Executive Director |
Jeffrey Cossman | 77 | 2017 | Independent Director |
Christina Rizopoulos Valauri | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review